Related Experiment Video
Updated: May 29, 2026

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
[Mitotane as possible cause of acute intermittent porphyria]
1Medicinsk Afdeling, Orkdal Sygehus, St. Olavs Hospital, 7300 Orkanger, Norge. finn.edler.von.eyben@stolav.no
Abstract:
A 54 year-old woman with acute intermittent porphyria (AIP) developed an attack of porphyria after 156 days of treatment with mitotane following a non-radical adrenalectomy for adrenocortical carcinoma. Mitotane therapy was discontinued but the attack of porphyria persisted for more than four months and included episodes with severe metabolic and neurologic toxicities. Mitotane is probably porphyrinogenic for patients with AIP.
More Related Videos
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Antiprotozoal Agents
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

